Your Genes Influence How Your Metabolism Works. We Map Those Tendencies Early
Your genes shape how your body stores fat, processes sugar, and regulates blood pressure. CENT AI’s metabolic panel analyzes thousands of DNA markers to reveal your true risk, so lifestyle can finally meet precision.
Why It’s Important?
The Stats You Can’t Ignore
CENT AI is built on clinical evidence and not assumptions. These genetic facts explain why early, accurate DNA analysis truly matters.
Twin and family studies estimate the heritability of type 2 diabetes between ~30% and 70%, depending on age and population, confirming a substantial genetic contribution.
Source: ScienceDirect
What all gets covered?
A Complete Genetic View of Your Metabolic Tendencies
NGS covers key genes involved in metabolic disorders, while PRS evaluates your overall genetic risk for diabetes, obesity, and related conditions.
Type 2 Diabetes
Genetic risk score for Type 2 Diabetes.
PRS
What We Test For
PRS measures genome-wide markers that influence insulin resistance, beta-cell function and glucose metabolism, giving an overall genetic risk for Type 2 Diabetes. Know more
Key Genes Analyzed
Genome-wide SNP markers associated with T2D and glycaemic traits from large studies.
High BMI
Genetic risk for high BMI and weight tendency.
PRS
What We Test For
PRS evaluates multiple genome-wide variants that together shape your tendency toward higher BMI, central obesity and weight gain. Know more
Key Genes Analyzed
Genome-wide SNP markers associated with with BMI, adiposity and body-fat distribution.
Hypertension
Genetic risk score for hypertension
PRS
What We Test For
PRS integrates genome-wide markers related to blood pressure and vascular tone, helping quantify your inherited risk for high BP alongside metabolic traits. Know more
Key Genes Analyzed
Genome-wide SNP markers for blood pressure and hypertension.
FAQ
Frequently Asked Questions
This screening analyses your DNA across all four major disease systems—Heart, Cancer, Neuro, and Metabolic—using both Next-Generation Sequencing (NGS) for high-impact genes and Polygenic Risk Scoring (PRS) for common, multi-gene risks.
Since your DNA doesn’t change, genetics is typically a once-in-a-lifetime test.
But your personalised screening plan is updated as medical science evolves.
Yes. Genetics allows you to:
Detect risks decades before symptoms
Personalise screening (MRI frequency, calcium score, cancer surveillance, etc.)
Modify lifestyle based on your actual biology
Take early actions that can reduce risk by 30–70%, depending on the condition
Most consumer DNA tests only analyse a few markers or ancestry data.
CENT AI performs clinical-grade sequencing + PRS across thousands of markers and medically important genes—validated for preventive healthcare, not recreation.
